ArticleCancer letters2012

Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progression.

Aninda Basu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.